OQ 80 (C-18130)
OQ80 1 Electrical Stimulation Therapy
Audio content
- Duration:
- 15:51 Minutes
- Speaker(s):
- Walter Wrobel, Polly Dulley
OQ80 2 Predicting Success with Low Vision Aids
Audio content
- Duration:
- 10:27 Minutes
- Speaker(s):
- Dr Keziah Latham, Susan Cowling
OQ80 3 Current state of Multifocal Intraocular implants
Audio content
- Duration:
- 8:36 Minutes
- Speaker(s):
- Vincenzo Maurino, Nicola Moss
OQ80 Quarterly Review
Audio content
- Duration:
- 13:10 Minutes
- Speaker(s):
- Geoff Roberson
- Closing Date:
- 06 March 2012
- Speaker(s):
- Presented by Geoff Watts
CET Points 1
Full Synopsis
Electrical Stimulation Therapy for Retinitis Pigmentosa – Walter Wrobel and Polly Dulley
Dr Walter Wrobel has developed, with his company Okuvision, an electrical stimulation therapy for retinitis pigmentosa which gained CE-approval in 2010, following successful clinical trials. He talks to Polly Dulley about how his approach differs from others in the field, and what hope it offers to patients with this type of retinal degeneration.
Predicting a patients likely success with Low Vision Aids – Dr Keziah Latham and Susan Cowling
This interview follows a discussion in OQ79 about low vision aids. Here, Susan Cowling talks to Dr Keziah Latham about her research into whether a patient’s success with low vision aids can be accurately predicted from standardized assessments of current vision levels and the spectacle strength.
The current state of Multifocal Intraocular implants – Vincenzo Maurino and Nicola Moss
With over 30% of people over 65 in the UK suffering from cataracts, their treatment remains an important area for ophthalmic research. While modern cataract surgery is most often accompanied by the insertion of a monofocal intraocular lens, other types of lenses are becoming increasingly popular, including the multifocal intraocular lens. Vincenzo Maurino from Moorfields Eye Hospital talks to Nicola Moss about recent developments in this area.
Quarterly Review – Geoff Roberson
This quarterly review opens with three papers on glaucoma. The first is a study of how the type of glaucoma a patient has influences the progression of visual field loss, and is followed by a paper revisiting the discussion over whether diabetes is a risk factor for glaucoma. The third article is an outline of a study into the usefulness of pachymetry in the referral of glaucoma and OHT patients by community optometrists. Geoff then moves onto a summary of two American clinical trials of treatments for wet AMD. The fifth paper models the prevalence of age-related macular degeneration in the UK over the 2010/2020 decade, and the final article details the positive results of a study of Lucentis treatment for patients with higher levels of VA.
More information
References:
Electrical stimulation therapy for retinitis pigmentosa
Schatz, A. et al. 2011. Transcorneal Electrical Stimulation for Patients with Retinitis Pigmentosa: A Prospective, Randomized, Sham-Controlled Exploratory Study. Invest. Ophthalmol Vis Sci 52(7), 4485-4496.
http://www.medicalnewstoday.com/releases/224224.php
Bourne RR. 2006, Worldwide glaucoma through the looking glass. Br J Ophthalmol. 90(3), 253-4.
Predicting success with low vision aids
http://www.keziahlatham.com/?p=162; further publications forthcoming.
Multifocal intraocular implants
de Vries NE, Webers C, Touwslager WRH, Bauer NJC, de Brabander J, Berendschot TT & Nuijts, RMMA. 2010. Dissatisfaction after implantation of multifocal intraocular lenses. J Cataract Refract Surg 37(5): 859-65.
Alió JL, Plaza-Puche AB, Piñero DP, Amparo F, Jiménez R, Rodríguez-Prats JL, Javaloy J, Pongo V. 2010. Optical analysis, reading performance, and quality-of-life evaluation after implantation of a diffractive multifocal intraocular lens. J Cataract Refract Surg 37(1), 27-37.
Cochener B, Fernández-Vega L, Alfonso JF, Maurel F, Meunier J & Berdeaux G. 2010. Spectacle independence and subjective satisfaction of ReSTOR multifocal intraocular lens after cataract or presbyopia surgery in two European countries. Clin Ophthalmol 2010(4), 81-9.
Stanojcic N, Wilkins M, Bunce C & Ionides A. 2010. Visual fields in patients with multifocal intraocular lens implants and monovision: an exploratory study. Eye 24, 1645-1651.
Quarterly review
de Moraes CG, Liebmann JM, Liebmann, CA, Susanna R, Jr, Tello C, Ritch R. 2011. Visual field progression outcomes in glaucoma subtypes. Acta Ophthalmol. DOI: 10.1111/j.1755-3768.2011.02260.x.
Primus S, Harris A, Siesky BA, Guidoboni G. 2011. Diabetes: a risk factor for glaucoma? Br J Ophthalmol. DOI: 10.1136/bjophthalmol-2011-300788.
Sandhu J, Pushpoth S, Birch M, Ray-Chaudhuri N. 2011. The role of pachymetry in primary care as a refinement tool of ocular hypertension and glaucoma referrals. Br J Ophthalmol. DOI: 10.1136/bjophthalmol-2011-300866.
Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. 2011. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364, 1897-1908.
Minassian DC, Reidy A, Lightstone A, Desai P. 2011. Modelling the prevalence of age-related macular degeneration (2010-2020) in the UK: expected impact of anti-vascular endothelial growth factor (VEGF) therapy. Br J Ophthalmol 95, 1433-1436.
Williams TA, Blyth CP. 2011. Outcome of ranibizumab treatment in neovascular age related macula degeneration in eyes with baseline visual acuity better than 6/12. Eye DOI: 10.1038/eye.2011.224.
Other Documents
MCQ test
